The risk for a severe exacerbation was decreased among patients with asthma using high-dose ICS/LABA vs medium-dose ICS/LABA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback